Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian the rough-skinned newt Taricha granulosa

Journal of Molecular Endocrinology

Volumn 34, Issue 1, 2005, Pages 247-256

  Walthers, Eliza A ^a   Bradford, C Samuel ^a   Moore, Frank L ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; COMPLEMENTARY DNA; DYNORPHIN B; DYNORPHIN[1-13]; DYNORPHIN[1-8]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; OPIATE AGONIST; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING COMPETITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG SYNTHESIS; GENE EXPRESSION; GENETIC TRANSFECTION; MOLECULAR CLONING; NEWT; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; LIGANDS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RECEPTORS, OPIOID; SALAMANDRIDAE; SEQUENCE ALIGNMENT;

EID: 14544275587     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01687     Document Type: Article

References (54)

1. Barrallo A, Gonzalez-Sarmiento R, Porteros A, Garcia-Isidoro M & Rodriguez RE 1998 Cloning, molecular characterization, and distribution of a gene homologous to delta opioid receptor from zebrafish (Danio rerio). Biochemical and Biophysical Research Communications 275 544-548.
2. Barrallo A, Gonzalez-Sarmiento R, Alvar F & Rodriguez RE 2000 ZFOR2, a new opioid receptor-like gene from the teleost zebrafish (Danio rerio). Brain Research Molecular Brain Research 84 1-6.
3. Benyhe S, Varga E, Hepp J, Magyar A, Borsodi A & Wollemann M 1990 Characterization of kappa 1 and kappa 2 opioid binding sites in frog (Rana esculenta) brain membrane preparation. Neurochemical Research 15 899-904.
4. Benyhe S, Szucs M, Borsodi A & Wollemann M 1992 Species differences in the stereoselectivity of kappa opioid binding sites for [3H]U-69593 and [3H]ethylketocyclazocine. Life Sciences 51 1647-1655.
5. 1-8 binding sites in frog (Rana Esculenta) brain membranes. Neuropeptides 26 359-361.
6. Borsodi A, Khan A, Simon J, Benyhe S, Hepp J, Wollemann M & Medzihradszky K 1986 Purification of kappa-opioid receptor subtype to apparent homogeneity from frog brain. NIDA Research Monograph 75 1-4.
7. Butour J, Moisand D, Mazarguil H, Mollereau D & Meunier J 1997 Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids. European Journal of Pharmacology 321 97-103.
8. Danielson PB & Dores RM 1999 Molecular evolution of the opioid/orphanin gene family. General and Comparative Endocrinology 113 169-186.
9. Danielson PB, Hoverstein MT, Fitzpatrick M, Schreck C, Akil H & Dores RM 2001 Sturgeon orphanin, a molecular 'fossil' that bridges the gap between the opioids and orphanin FQ/nociceptin. Journal of Biological Chemistry 276 22114-22119.
10. Darlison MG, Greten FR, Harvey RJ, Kreienkamp H-J, Stuhmer T, Zwiers H, Lederis K & Richter D 1997 Opioid receptors from a lower vertebrate (Catostomus commersoni): Sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution. PNAS 94 8214-8219.
11. Deviche P & Moore FL 1987 Opioid κ-receptor agonists suppress sexual behaviors in male rough-skinned newts (Taricha granulosa). Hormones and Behavior 21 371-383.
12. Deviche P, Lowry CA & Moore FL 1989 Opiate control of spontaneous locomotor activity in a urodele amphibian. Pharmacology Biochemisty and Behavior 34 753-757.
13. Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rand E & Strader CD 1987 Structural features required for ligand binding to the beta-adrenergic receptor. EMBO Journal 11 3269-3275.
14. Dores RM, McDonald LK, Goldsmith A, Deviche P & Rubin DA 1993 The phylogeny of enkephalins: speculations on the origins of opioid precursors. Cellular Physiology and Biochemistry 3 231-244.
15. Douglass J, Civelli O & Herbert E 1984 Polyprotein gene expression: generation of diversity of neuroendocrine peptides. Annual Review of Biochemistry 53 665-715.
16. 3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site. Journal of Molecular and Cellular Cardiology 30 2751-2760.
17. Giuliani S, Lecci A, Tramontana M & Maggi CA 1998 The inhibitory effect of nociceptin on the micturition reflex in anaesthetized rats. British Journal of Pharmacology 118 1567-1569.
18. Karnik SS, Sakmar TP, Chen HB & Khorana HG 1988 Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. PNAS 22 8459-8463.
19. Law PY, Wong YH & Loh HH 1999 Mutational analysis of the structure and function of opioid receptors. Biopolymers (Peptide Science) 51 440-455.
20. Law PY, Wong YH & Loh HH 2000 Molecular mechanisms and regulation of opioid receptor signaling. Annual Review of Pharmacology and Toxicology 40 389-430.
21. Lefkowitz RJ, Hausdorff WP & Caron MG 1990 Role of phosphorylation in desensitization of the beta-adrenoceptor. Trends in Pharmacological Sciences 11 190-194.
22. Li X, Keith Jr DE & Evans CJ 1996 Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. FEBS Letters 397 25-29.
23. Lowry CA, Deviche P & Moore FL 1990 Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion. Brain Research 513 94-100.
24. Makimura M, Ito Y & Murakoshi Y 1988 Characterization of opioid receptor from bullfrog brain. Japanese Journal of Pharmacology 8 359-366.
25. Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O & Akil H 1996a Moving from the Orphanin FQ receptor to an opioid receptor using four point mutations. Journal of Biological Chemistry 271 32016-32020.
26. Meng F, Ueda Y, Hoverstein MT, Thompson RC, Taylor L, Watson SJ & Akil H 1996b Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands. European Journal of Pharmacology 311 285-292.
27. Meng F, Ueda Y, Hoversten HT, Taylor UP, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O & Akil H 1998 Creating a functional opioid alkaloid binding site in the Orphanin FQ receptor through site-directed mutagenesis. Molecular Pharmacology 53 772-777.
28. Meunier J-C 1997 Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. European Journal of Pharmacology 340 1-15.
29. 1 receptor. Nature 377 532-535.
30. Minami M & Satoh M 1995 Molecular biology of the opioid receptors: structures, functions and distributions. Neuroscience Research 23 121-145.
31. Mollereau C & Mouledous L 2000 Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21 907-917.
32. Mollereau C, Pascaud A, Baillat G, Mazarguil H, Puget A & Meunier J-C 1988 Evidence for a new type of opioid binding site in the brain of the frog Rana ridibunda. European Journal of Pharmacology 150 75-84.
33. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G & Meunier J-C 1994 ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Letters 341 33-38.
34. Mouledous L, Topham CM, Moisand C, Mollereau C & Meunier J-C 2000 Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain. Molecular Pharmacology 52 495-502.
35. Newman LC, Sands SS, Wallace DR & Stevens CW 2002 Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates. Journal of Pharmacology and Experimental Therapeutics 301 364-370.
36. O'Dowd BF, Hnatowich M, Caron MG, Lefkowitz RJ, & Bouvier M 1989 Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. Journal of Biological Chemistry 264 12657-12665.
37. Osinski MA, Pampusch MS, Murtaugh MP & Brown DR 1999 Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract. European Journal of Pharmacology 365 281-289.
38. Ovchinnikov YuA, Abdulaev NG & Bogachuk AS 1988 Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated. FEBS Letters 230 1-5.
39. Pezalla PD 1983 Morphine-induced analgesia and explosive motor behavior in an amphibian. Brain Research 273 297-305.
40. Reinscheid RK, Nothacker H-P, Bourson A, Ardat A, Henningsen RA, Bunsow JR, Grandy DK, Langen H, Monsma Jr FJ & Civelli O 1995 Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270 792-794.
41. Rizzi A, Calo G, Trevisani M, Tognetto M, Fabbri L, Mapp C, Guerrini R, Salvadori S, Regoli D & Geppetti P 1999 Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sciences 64 PL157-PL163.
42. Rodriguez RE, Barrallo A, Garcia-Malvar F, McFadyen IJ, Gonzalez-Sarmiento R & Traynor JR 2000 Characterization of ZFOR1, a putative delta-opioid receptor from the teleost zebrafish (Danio rerio). Neuroscience Letters 288 207-210.
43. Ruegg UT, Hiller JM & Simon EJ 1980 Solubilization of an active opiate receptor from Bufo marinus. European Journal of Pharmacology 64 367-368.
44. Ruegg UT, Cuenod S, Hiller JM, Gioannini TC, Howells RD & Simon EJ 1981 Characterization and partial purification of solubilized active opiate receptor from toad brain. PNAS 78 4635-4638.
45. Simon EJ, Hiller JM, Groth J, Itzhak Y, Holland MJ & Beck SG 1982 The nature of opiate receptors in toad brain. Life Sciences 31 1367-1370.
46. Simon J, Szucs M, Benyhe S, Sorsodi A, Zeman P & Wollemann M 1984 Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain. Journal of Neurochemistry 43 957-963.
47. Simon J, Benyhe S, Borsodi A, Szucs M & Wollemann M 1985 Separation of kappa-opioid receptor subtype from frog brain. FEBS Letters 183 395-397.
48. Simon J, Benyhe S, Hepp J, Khan A, Borsodi A, Szucs M, Medzihradszky K & Wollemann M 1987 Purification of a kappa-opioid receptor subtype from frog brain. Neuropeptides 10 19-28.
49. Stevens CW & Pezalla PD 1983 A spinal site mediates opiate analgesia in frogs. Life Sciences 33 2097-2103.
50. Stevens CW, Pezalla PD & Yaksh TL 1987 Spinal antinociceptive action of three representative opioid peptides in frogs. Brain Research 402 201-203.
51. Waldhoer M, Bartlett S, & Whistler J 2004 Opioids receptors. Annual Review of Biochemistry 73 953-990.
52. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM & Uhl GR 1994 cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Letters 348 75-79.
53. Wang WW, Shahrestanifar M, Jin J & Howells RD 1995 Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. PNAS 92 12436-12440.
54. 7 binding to opioid receptors in frog brain membrane preparations. Journal of Neurochemistry 63 1460-1465.